Orion
39,93 EUR +1,04 %12.857 investorer følger denne virksomhed
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo.
P/E (23e)
28,7
EV/EBIT (23e)
21,47
P/B (23e)
6,38
Udbytteafkast, % (23e)
4,26 %
Kursmål
45.00 EUR
Anbefaling
Reducer
Opdateret
27.4.2023
NASDAQ Helsinki
ORNBV
Daglig lav / høj pris
39,35 / 39,96
EUR
Markedsværdi
4,28 mia. EUR
Aktieomsætning
3,83 mio. EUR
Volumen
96 t
Risiko og anbefaling
HøjRisikoLav
SælgAnbefalingKøb
Analyst
Antti Siltanen
Analytiker
Pauli Lohi
Analytiker
Seneste videoer
Finanskalender
Delårsrapport
17.07.2023
Delårsrapport
26.10.2023
Resultatopgørelse
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| Omsætning | 1.051,00 | 1.078,10 | 1.041,10 | 1.340,60 | 1.181,28 | 1.290,46 | 1.418,48 | 1.517,77 |
| vækst-% | 7,52 % | 2,58 % | -3,43 % | 28,77 % | -11,88 % | 9,24 % | 9,92 % | 7,00 % |
| EBITDA | 308,90 | 336,50 | 289,04 | 486,60 | 298,69 | 330,77 | 374,51 | 425,87 |
| EBIT (adj.) | 252,80 | 280,10 | 243,34 | 439,60 | 248,09 | 292,94 | 336,18 | 387,03 |
| EBIT | 252,80 | 280,10 | 243,34 | 439,60 | 248,09 | 292,94 | 336,18 | 387,03 |
| Overskud før skat | 250,84 | 278,30 | 242,34 | 440,30 | 247,00 | 291,89 | 334,11 | 384,49 |
| Netto indkomst | 200,36 | 219,85 | 193,79 | 349,50 | 195,41 | 230,60 | 263,95 | 303,75 |
| EPS (adj.) | 1,42 | 1,57 | 1,38 | 2,49 | 1,39 | 1,64 | 1,88 | 2,16 |
| vækst-% | 1,54 % | 9,91 % | -11,85 % | 80,35 % | -44,09 % | 18,01 % | 14,46 % | 15,08 % |
| Udbytte | 1,50 | 1,50 | 1,50 | 1,60 | 1,70 | 1,80 | 1,90 | 2,00 |
| Udbytte ratio | 105,33 % | 95,84 % | 108,72 % | 64,30 % | 122,20 % | 109,64 % | 101,11 % | 92,49 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 29,39 % | 31,21 % | 27,76 % | 36,30 % | 25,29 % | 25,63 % | 26,40 % | 28,06 % |
| EBIT-% (adj.) | 24,05 % | 25,98 % | 23,37 % | 32,79 % | 21,00 % | 22,70 % | 23,70 % | 25,50 % |
| EBIT-% | 24,05 % | 25,98 % | 23,37 % | 32,79 % | 21,00 % | 22,70 % | 23,70 % | 25,50 % |
| ROE | 25,81 % | 29,11 % | 26,81 % | 43,08 % | 21,87 % | 26,37 % | 30,13 % | 33,75 % |
| ROI | 29,52 % | 34,41 % | 29,54 % | 45,56 % | 24,33 % | 31,05 % | 33,69 % | 36,97 % |
Værdiansættelse
| 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e | |
|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 41,27 | 37,53 | 36,52 | 51,24 | 39,93 | 39,93 | 39,93 | 39,93 |
| Aktier | 140,70 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 | 140,46 |
| Markedsværdi | 5.806,50 | 5.271,57 | 5.129,70 | 7.197,31 | 5.608,68 | 5.608,68 | 5.608,68 | 5.608,68 |
| Enterprise value | 5.667,50 | 5.085,78 | 4.940,34 | 7.078,71 | 5.327,54 | 5.354,75 | 5.369,13 | 5.342,60 |
| EV/S | 5,39 | 4,72 | 4,75 | 5,28 | 4,51 | 4,15 | 3,79 | 3,52 |
| EV/EBITDA | 18,35 | 15,11 | 17,09 | 14,55 | 17,84 | 16,19 | 14,34 | 12,55 |
| EV/EBIT (adj.) | 22,42 | 18,16 | 20,30 | 16,10 | 21,47 | 18,28 | 15,97 | 13,80 |
| EV/EBIT | 22,42 | 18,16 | 20,30 | 16,10 | 21,47 | 18,28 | 15,97 | 13,80 |
| P/E (adj.) | 28,98 | 23,98 | 26,47 | 20,59 | 28,70 | 24,32 | 21,25 | 18,46 |
| P/E | 28,98 | 23,98 | 26,47 | 20,59 | 28,70 | 24,32 | 21,25 | 18,46 |
| P/B | 7,45 | 7,21 | 7,18 | 7,93 | 6,38 | 6,44 | 6,36 | 6,11 |
| P/S | 5,52 | 4,89 | 4,93 | 5,37 | 4,75 | 4,35 | 3,95 | 3,70 |
| Udbytteprocent | 3,63 % | 4,00 % | 4,11 % | 3,12 % | 4,26 % | 4,51 % | 4,76 % | 5,01 % |
| Equity ratio | 75,25 % | 65,56 % | 66,03 % | 60,39 % | 68,60 % | 64,66 % | 62,18 % | 62,74 % |
| Gearing ratio | -17,83 % | -25,41 % | -26,51 % | -13,06 % | -32,00 % | -29,17 % | -27,17 % | -28,97 % |
Kvartalsdata
| Q2/22 | Q3/22 | Q4/22 | 2022 | Q1/23 | Q2/23e | Q3/23e | Q4/23e | 2023e | |
|---|---|---|---|---|---|---|---|---|---|
| Omsætning | 283,70 | 491,80 | 294,50 | 1.340,60 | 277,90 | 290,93 | 282,28 | 330,17 | 1.181,28 |
| EBITDA | 93,60 | 256,78 | 53,23 | 486,60 | 67,67 | 76,81 | 72,08 | 82,14 | 298,69 |
| EBIT | 82,00 | 245,40 | 40,70 | 439,60 | 55,47 | 64,01 | 59,28 | 69,34 | 248,09 |
| Overskud før skat | 83,10 | 244,60 | 40,50 | 440,30 | 55,13 | 63,76 | 59,03 | 69,09 | 247,00 |
| Netto indkomst | 66,10 | 194,40 | 31,70 | 349,50 | 43,83 | 50,37 | 46,63 | 54,58 | 195,41 |
Viser Alle indholdstyper
